Paper Details

  1. Home
  2. Paper Details

Effects of dabigatran versus warfarin on 2-year cognitive outcomes in old patients with atrial fibrillation: results from the GIRAF randomized clinical trial.

Author: AmadoDaniel K, Borges-JuniorFlavio A, BruckiSonia M D, CalderaroDaniela, CaramelliBruno, CaramelliPaulo, CardozoFrancisco A M, Escalante-RojasMaria C, GualandroDanielle M, MagalhãesIuri R, MatheusMariana G, NitriniRicardo, PastanaAdriana F, RodriguesAna Carolina O, SperaRaphael R, TavaresCaio A M, YuPai Ching

Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Dabigatran is a newer blood thinner that may reduce cognitive decline in older patients with atrial fibrillation compared to warfarin. While observational studies suggest a benefit, conclusive data are still lacking.
Paper Details　
Original Abstract of the Article :
Observational studies support a role for oral anticoagulation to reduce the risk of dementia in atrial fibrillation patients, but conclusive data are lacking. Since dabigatran offers a more stable anticoagulation, we hypothesized it would reduce cognitive decline when compared to warfarin in old pat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598018/

データ提供：米国国立医学図書館（NLM）

Dabigatran vs. Warfarin: Cognitive Outcomes in Atrial Fibrillation

Atrial fibrillation, an irregular heartbeat, is a common condition that can significantly impact quality of life. This study focuses on the potential cognitive effects of different anticoagulants, dabigatran and warfarin, in patients with atrial fibrillation. The researchers hypothesized that dabigatran, with its more stable anticoagulation properties, may reduce cognitive decline compared to warfarin. This study, like a meticulous exploration of the desert of cognitive function, aims to understand the potential impact of anticoagulants on brain health.

Investigating the Cognitive Effects of Anticoagulants

The study aims to provide further insights into the potential cognitive implications of different anticoagulant therapies for atrial fibrillation. The results could potentially guide clinicians in selecting the most appropriate anticoagulant for each patient, balancing the risks and benefits of each medication.

Navigating the Complexities of Anticoagulation

This research highlights the importance of considering cognitive outcomes when choosing anticoagulants for atrial fibrillation patients. By carefully weighing the potential risks and benefits of each medication, clinicians can help their patients make informed decisions that prioritize both cardiovascular health and cognitive well-being.

Dr. Camel's Conclusion

This study delves into the complexities of anticoagulant therapy for atrial fibrillation, exploring the potential cognitive impact of different medications. The findings could offer valuable insights for clinicians, helping them to choose the most appropriate anticoagulant for individual patients, balancing the benefits of preventing stroke with the potential for cognitive decline. It's a reminder that the desert of medical research is a vast and complex landscape, with new discoveries emerging all the time.

Date :
  1. Date Completed 2022-10-27
  2. Date Revised 2022-11-04
Further Info :

Pubmed ID

36284318

DOI: Digital Object Identifier

PMC9598018

Related Literature

Article Analysis
・Effects of dabigatran
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.